Rheumatoid arthritis

Hideto Kameda, Tsutomu Takeuchi

研究成果: Review article査読

抄録

Pathogenesis of rheumatoid arthritis is likely to implicate anti-citrullinated protein/ peptide antibody(ACPA) and an immunodistortion including abnormal T cell subpopulation. Based on above and other recent findings, new biological agents targeted to inflammatory cytokines such as tocilizumab, activated T cells (abatacept) or B cells (ocrelizumab), as well as new small molecule drugs such as JAK3 inhibitor, are sure to further facilitate remission without impaired activity of daily life in patients with RA. The contribution of Japanese physician-scientists to the progress in rheumatology has been significant as described in this review, and it must be increasingly greater in the near future.

本文言語English
ページ(範囲)495-499
ページ数5
ジャーナルNippon rinsho. Japanese journal of clinical medicine
67
3
出版ステータスPublished - 2009 3月
外部発表はい

ASJC Scopus subject areas

  • 医学一般

フィンガープリント

「Rheumatoid arthritis」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル